Chemoinformaics analysis of Heptadecyl octadecanoate
| Molecular Weight | 522.943 | nRot | 32 |
| Heavy Atom Molecular Weight | 452.383 | nRig | 6 |
| Exact Molecular Weight | 522.538 | nRing | 0 |
| Solubility: LogS | -0.267 | nHRing | 0 |
| Solubility: LogP | 1.553 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 107 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 106.73 |
| nHD | 0 | BPOL | 72.8285 |
| QED | 0.586 |
| Synth | 2.419 |
| Natural Product Likeliness | -0.741 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.006 |
| CACO-2 | -4.576 |
| MDCK | 0.0000299 |
| BBB | 0.979 |
| PPB | 0.473973 |
| VDSS | 1.613 |
| FU | 0.576785 |
| CYP1A2-inh | 0.711 |
| CYP1A2-sub | 0.909 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.62 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.3 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.768 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.4 |
| CL | 7.102 |
| T12 | 0.372 |
| hERG | 0.019 |
| Ames | 0.009 |
| ROA | 0.298 |
| SkinSen | 0.382 |
| Carcinogencity | 0.595 |
| EI | 0.98 |
| Respiratory | 0.821 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.530806 |